Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse

scientific article published in June 1991

Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0041-008X(91)90167-D
P698PubMed publication ID2068722

P2093author name stringFisher JW
Andersen ME
Allen BC
Gargas ML
P433issue2
P921main subjectpharmacokineticsQ323936
P304page(s)183-195
P577publication date1991-06-01
P1433published inToxicology and Applied PharmacologyQ2446974
P1476titlePhysiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse
P478volume109

Reverse relations

cites work (P2860)
Q46448853A spreadsheet program for modeling quantitative structure-pharmacokinetic relationships for inhaled volatile organics in humans
Q43733639An in vitro model for evaluation of vaporous toxicity of trichloroethylene and tetrachloroethylene to CHO-K1 cells
Q35961038Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene
Q40300648Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites
Q37916566Challenges in the application of quantitative approaches in risk assessment: a case study with di-(2-ethylhexyl)phthalate
Q90573663Comparative analysis of metabolism of trichloroethylene and tetrachloroethylene among mouse tissues and strains
Q37031081Development and specification of physiologically based pharmacokinetic models for use in risk assessment
Q33916714Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment
Q51672014Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models.
Q51582192Exploration of an interaction threshold for the joint toxicity of trichloroethylene and 1,1-dichloroethylene: utilization of a PBPK model.
Q51607142Factors affecting species differences in the kinetics of metabolites of trichloroethylene.
Q57200055Feasibility of metabolic parameter estimation in pharmacokinetic models of carbon tetrachloride exposure in rats1
Q44934154Incorporation of acute dynamic ventilation changes into a standardized physiologically based pharmacokinetic model
Q35039326Issues in the pharmacokinetics of trichloroethylene and its metabolites
Q81014006Magnitude and mechanistic determinants of the interspecies toxicokinetic uncertainty factor for organic chemicals
Q34563187Mathematical modelling and quantitative methods
Q52416376Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice
Q34657985Metabolism and tissue distribution of orally administered trichloroethylene in male and female rats: identification of glutathione- and cytochrome P-450-derived metabolites in liver, kidney, blood, and urine
Q33916680Metabolism of trichloroethylene
Q43215658Molecular structure-based prediction of the steady-state blood concentrations of inhaled organics in rats
Q46601305Moving from external exposure concentration to internal dose: duration extrapolation based on physiologically based pharmacokinetic derived estimates of internal dose
Q37333030Pharmacokinetic analysis of trichloroethylene metabolism in male B6C3F1 mice: Formation and disposition of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine
Q51672021Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans.
Q33916709Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites
Q47843571Physiologically-based pharmacokinetic model for trichloroethylene considering enterohepatic recirculation of major metabolites
Q45937111Reliability of using urinary and blood trichloroacetic acid as a biomarker of exposure to chlorinated drinking water disinfection byproducts.
Q51685443Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate
Q35134337Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics
Q40872640Trichloroethylene health risk assessment: a new and improved process
Q51558607Trichloroethylene metabolism in vitro: an EPR/SPIN trapping study.
Q51541270Trichloroethylene radicals generated by ionizing radiation. An EPR/spin trapping study

Search more.